Table 3.
KEGG pathways involved in genes whose expression levels were changed by Y4RNAfr.
| Cell | Term | Count | % | P-Value |
|---|---|---|---|---|
| HL60 | Tight junction | 4 | 3.1 | 5.10E-03 |
| Olfactory transduction | 5 | 3.8 | 7.60E-02 | |
| Histidine metabolism |
2 |
1.5 |
8.60E-02 |
|
| RPMI-8226 | Antigen processing and presentation | 7 | 1.8 | 5.00E-04 |
| Type I diabetes mellitus | 5 | 1.3 | 2.30E-03 | |
| Autoimmune thyroid disease | 5 | 1.3 | 5.00E-03 | |
| Staphylococcus aureus infection | 5 | 1.3 | 5.70E-03 | |
| Asthma | 4 | 1 | 7.20E-03 | |
| Graft-versus-host disease | 4 | 1 | 9.50E-03 | |
| Allograft rejection | 4 | 1 | 1.30E-02 | |
| Toxoplasmosis | 6 | 1.5 | 1.60E-02 | |
| Intestinal immune network for IgA production | 4 | 1 | 2.50E-02 | |
| Tuberculosis | 7 | 1.8 | 3.10E-02 | |
| Neuroactive ligand-receptor interaction | 9 | 2.3 | 3.10E-02 | |
| Viral myocarditis | 4 | 1 | 4.00E-02 | |
| PI3K-Akt signaling pathway | 10 | 2.6 | 4.00E-02 | |
| Phagosome | 6 | 1.5 | 5.00E-02 | |
| Inflammatory bowel disease (IBD) | 4 | 1 | 5.40E-02 | |
| Regulation of actin cytoskeleton | 7 | 1.8 | 6.20E-02 | |
| Leishmaniasis | 4 | 1 | 6.90E-02 | |
| Pathways in cancer | 10 | 2.6 | 7.90E-02 | |
| Influenza A | 6 | 1.5 | 8.30E-02 | |
| Olfactory transduction |
10 |
2.6 |
8.50E-02 |
|
| HEK293 | Complement and coagulation cascades | 4 | 2.5 | 4.60E-03 |
| Staphylococcus aureus infection | 3 | 1.9 | 2.90E-02 | |
| Arachidonic acid metabolism | 3 | 1.9 | 3.60E-02 | |
| Salmonella infection | 3 | 1.9 | 6.30E-02 | |
| Rheumatoid arthritis | 3 | 1.9 | 7.00E-02 | |
| Toll-like receptor signaling pathway | 3 | 1.9 | 9.60E-02 |